Hotung's investee company Crystalvue lists on Taipei Exchange
MAINBOARD-LISTED Hotung Investment Holdings' investee company, Crystalvue Medical Corporation, has listed on the Taipei Exchange on Dec 25, the venture capital investment group said on Wednesday.
Crystalvue's initial public offering share price was set at NT$58.80, according to a Taiwan Stock Exchange media statement.
Taiwan-based Crystalvue engages mainly in the research, development, manufacture and sale of ophthalmic diagnostic medical devices.
It is also the sole distributor of a brand of gastrointestinal endoscopic disposable devices.
It has developed its own eye diagnostic products such as the fundus camera and automatic non-contact tonometer.
Shares of Hotung Investment remained unchanged at S$1.74 as at 9.38am.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Telegram messaging service to allow Tether stablecoin payments
Hong Kong regulator to probe PwC auditing role over Evergrande
US: S&P, Dow open flat as Middle East jitters ease, Netflix weighs on Nasdaq
DBS puts 46 retail units, HDB shops on market for S$210 million
China to facilitate Hong Kong IPOs and expand Stock Connect
Global equity funds see surge in outflows as rate cut hopes fade